Brand · Injection · Updated Nov 11, 2026
Epogen 2000 units/mL, 1 mL injection price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for epogen 2000 units/ml, 1 ml injection and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Epogen 2000 units/mL, 1 mL price history
What pharmacies pay for 10 mL, weekly- Now
- $322.67
- 52-week low
- $322.67
- 52-week high
- $323.64
- A year ago
- $323.64
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Sep 23, 2026 | $32.27 | $32.27 | No change | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $32.35 | $32.27 | -0.2% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $32.35 | $32.35 | No change | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $32.36 | $32.35 | No change | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $32.36 | $32.36 | No change | pharmacies' invoice prices changed (survey) |
| Feb 18, 2026 | $32.36 | $32.36 | No change | pharmacies' invoice prices changed (survey) |
| Sep 17, 2025 | $32.35 | $32.36 | No change | pharmacies' invoice prices changed (survey) |
Prices per mL. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for epogen 2000 units/ml, 1 ml injection
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell epogen 2000 units/ml, 1 ml injection under 2 package codes (NDCs). Pharmacies pay the same per mL whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Amgen, Inc | 55513-126-10 55513-126-20 | $32.27 |
All 2 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other epogen strengths and forms
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 4000 units/mL, 1 mL injection Brand | $64.36 | $643.64 / 10 mL | ||
| 10000 units/mL, 1 mL injection Brand | $161.82 | $1,618.21 / 10 mL | ||
| 20000 units/mL injection Brand | Not priced this week | |||
Official label & what changed
These highlights do not include all the information needed to use EPOGEN safely and effectively. See full prescribing information for EPOGEN. EPOGEN® (epoetin alfa) injection, for intravenous or subcutaneous useInitial U.S. Approval: 1989
WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
Chronic Kidney Disease:
In controlled trials, patients with chronic kidney disease (CKD) experienced greater risks for death, serious adverse cardiovascular reactions, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target a hemoglobin level of greater than 11 g/dL [see Warnings and Precautions (5.1)].
No trial has identified a hemoglobin target level, ESA dose, or dosing strategy that does not increase these risks [see Dosage and Administration (2.2)].
Use the lowest Epogen dose sufficient to reduce the need for red blood cell (RBC) transfusions [see Warnings and Precautions (5.1)].
Cancer:
ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in clinical studies of patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers [see Warnings and Precautions (5.2)].
To decrease these risks, as well as the risk of serious cardiovascular and thromboembolic reactions, use the lowest dose needed to avoid RBC transfusions [see Dosage and Administration (2.4)].
Use ESAs only for anemia from myelosuppressive chemotherapy [see Indications and Usage (1.3)].
ESAs are not indicated for patients receiving myelosuppressive chemotherapy when the anticipated outcome is cure [see Indications and Usage (1.5)].
Discontinue following the completion of a chemotherapy course [see Dosage and Administration (2.4)].
Perisurgery:
Due to increased risk of Deep Venous Thrombosis (DVT), DVT prophylaxis is recommended [see Dosage and Administration (2.5), Warnings and Precautions (5.1)].
WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
See full prescribing information for complete boxed warning.
Chronic Kidney Disease:
In controlled trials, patients experienced greater risks for death, serious adverse cardiovascular reactions, and stroke when administered erythropoiesis-stimulating agents (ESAs) to target a hemoglobin level of greater than 11 g/dL (5.1).
No trial has identified a hemoglobin target level, ESA dose, or dosing strategy that does not increase these risks (2.2).
Use the lowest Epogen dose sufficient to reduce the need for red blood cell (RBC) transfusions (5.1).
Cancer:
ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in clinical studies of patients with breast, non-small cell lung, head and neck, lymphoid, and cervical cancers (5.2).
Use the lowest dose to avoid RBC transfusions (2.4).
Use ESAs only for anemia from myelosuppressive chemotherapy (1.3).
ESAs are not indicated for patients receiving myelosuppressive chemotherapy when the anticipated outcome is cure (1.5).
Discontinue following the completion of a chemotherapy course (2.4).
Perisurgery:
Due to increased risk of deep venous thrombosis (DVT), DVT prophylaxis is recommended (5.1).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about epogen 2000 units/ml, 1 ml injection
How much does epogen 2000 units/ml, 1 ml injection cost without insurance?
Pharmacies pay about $322.67 for 10 mL ($32.27 per mL) as of November 11, 2026. A fair cash price is about $381.57: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $381.07 including shipping.
Is my price for epogen 2000 units/ml, 1 ml injection fair?
Compare it with the fair cash price of $381.57 for 10 mL. Up to about $476.96 is fair; above $763.14 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is epogen 2000 units/ml, 1 ml injection getting more expensive?
Over the last four weeks the price pharmacies pay held steady. Over a year it is about the same. See the 52-week chart.
Who makes epogen 2000 units/ml, 1 ml injection?
1 company: Amgen, Inc. See every package code.
Is epogen in shortage?
No shortage is reported right now. We check every day.
Has epogen been recalled?
1 recall on record. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about epogen 2000 units/ml, 1 ml injection
No comments yet. Questions, tips, what worked for you - start the conversation.